S100B  ||| S:0 E:6 ||| NNP
protein  ||| S:6 E:14 ||| NN
serum  ||| S:14 E:20 ||| NN
level  ||| S:20 E:26 ||| NN
as  ||| S:26 E:29 ||| IN
a  ||| S:29 E:31 ||| DT
biomarker  ||| S:31 E:41 ||| NN
of  ||| S:41 E:44 ||| IN
minor  ||| S:44 E:50 ||| JJ
head  ||| S:50 E:55 ||| NN
injury  ||| S:55 E:62 ||| NN
S100B  ||| S:62 E:68 ||| NN
is  ||| S:68 E:71 ||| VBZ
a  ||| S:71 E:73 ||| DT
small  ||| S:73 E:79 ||| JJ
protein  ||| S:79 E:87 ||| NN
selectively  ||| S:87 E:99 ||| RB
synthesized  ||| S:99 E:111 ||| VBN
by  ||| S:111 E:114 ||| IN
cerebral  ||| S:114 E:123 ||| JJ
astroglial  ||| S:123 E:134 ||| JJ
cells ||| S:134 E:139 ||| NNS
.  ||| S:139 E:141 ||| .
S100B  ||| S:141 E:147 ||| NNP
participates  ||| S:147 E:160 ||| VBZ
physiologically  ||| S:160 E:176 ||| VBN
in  ||| S:176 E:179 ||| IN
the  ||| S:179 E:183 ||| DT
regulation  ||| S:183 E:194 ||| NN
of  ||| S:194 E:197 ||| IN
intracellular  ||| S:197 E:211 ||| JJ
free  ||| S:211 E:216 ||| JJ
calcium  ||| S:216 E:224 ||| NN
levels ||| S:224 E:230 ||| NNS
,  ||| S:230 E:232 ||| ,
and  ||| S:232 E:236 ||| CC
exerts  ||| S:236 E:243 ||| VBG
a  ||| S:243 E:245 ||| DT
neurotrophic  ||| S:245 E:258 ||| JJ
activity  ||| S:258 E:267 ||| NN
on  ||| S:267 E:270 ||| IN
cerebral  ||| S:270 E:279 ||| JJ
cells ||| S:279 E:284 ||| NNS
.  ||| S:284 E:286 ||| .
The  ||| S:286 E:290 ||| DT
interest  ||| S:290 E:299 ||| NN
of  ||| S:299 E:302 ||| IN
S100B  ||| S:302 E:308 ||| CD
protein  ||| S:308 E:316 ||| NN
in  ||| S:316 E:319 ||| IN
clinical  ||| S:319 E:328 ||| JJ
biology  ||| S:328 E:336 ||| NN
results  ||| S:336 E:344 ||| NNS
from  ||| S:344 E:349 ||| IN
its  ||| S:349 E:353 ||| PRP$
physiological  ||| S:353 E:367 ||| JJ
presence  ||| S:367 E:376 ||| NN
in  ||| S:376 E:379 ||| IN
biological  ||| S:379 E:390 ||| JJ
fluids  ||| S:390 E:397 ||| NNS
( ||| S:397 E:398 ||| -LRB-
cerebrospinal  ||| S:398 E:412 ||| JJ
fluid ||| S:412 E:417 ||| NN
,  ||| S:417 E:419 ||| ,
blood ||| S:419 E:424 ||| NN
,  ||| S:424 E:426 ||| ,
urine ||| S:426 E:431 ||| CD
)  ||| S:431 E:433 ||| -RRB-
and  ||| S:433 E:437 ||| CC
from  ||| S:437 E:442 ||| IN
significant  ||| S:442 E:454 ||| JJ
increased  ||| S:454 E:464 ||| JJ
levels  ||| S:464 E:471 ||| NNS
when  ||| S:471 E:476 ||| WRB
an  ||| S:476 E:479 ||| DT
acute  ||| S:479 E:485 ||| JJ
brain  ||| S:485 E:491 ||| NN
injury  ||| S:491 E:498 ||| NN
occurred ||| S:498 E:506 ||| VBD
,  ||| S:506 E:508 ||| ,
from  ||| S:508 E:513 ||| IN
vascular  ||| S:513 E:522 ||| NNS
( ||| S:522 E:523 ||| -LRB-
intracranial  ||| S:523 E:536 ||| FW
hemorrhage ||| S:536 E:546 ||| FW
,  ||| S:546 E:548 ||| ,
ischemic  ||| S:548 E:557 ||| JJ
stroke ||| S:557 E:563 ||| NN
)  ||| S:563 E:565 ||| -RRB-
or  ||| S:565 E:568 ||| CC
traumatic  ||| S:568 E:578 ||| NNS
( ||| S:578 E:579 ||| -LRB-
traumatic  ||| S:579 E:589 ||| JJ
brain  ||| S:589 E:595 ||| NN
injury ||| S:595 E:601 ||| NN
)  ||| S:601 E:603 ||| -RRB-
origins ||| S:603 E:610 ||| NNS
.  ||| S:610 E:612 ||| .
Thus ||| S:612 E:616 ||| RB
,  ||| S:616 E:618 ||| ,
elevated  ||| S:618 E:627 ||| VBD
plasma  ||| S:627 E:634 ||| JJ
concentrations  ||| S:634 E:649 ||| NNS
of  ||| S:649 E:652 ||| IN
S100B  ||| S:652 E:658 ||| NNP
were  ||| S:658 E:663 ||| VBD
significantly  ||| S:663 E:677 ||| RB
increased  ||| S:677 E:687 ||| VBN
in  ||| S:687 E:690 ||| IN
patients  ||| S:690 E:699 ||| NNS
with  ||| S:699 E:704 ||| IN
a  ||| S:704 E:706 ||| DT
minor ||| S:706 E:711 ||| JJ
,  ||| S:711 E:713 ||| ,
moderate  ||| S:713 E:722 ||| JJ
and  ||| S:722 E:726 ||| CC
of  ||| S:726 E:729 ||| IN
course  ||| S:729 E:736 ||| NN
severe  ||| S:736 E:743 ||| JJ
traumatic  ||| S:743 E:753 ||| JJ
brain  ||| S:753 E:759 ||| NN
injury ||| S:759 E:765 ||| NN
.  ||| S:765 E:767 ||| .
By  ||| S:767 E:770 ||| IN
contrast ||| S:770 E:778 ||| NN
,  ||| S:778 E:780 ||| ,
serum  ||| S:780 E:786 ||| CD
S100B  ||| S:786 E:792 ||| CD
levels  ||| S:792 E:799 ||| NNS
remained  ||| S:799 E:808 ||| VBD
unchanged  ||| S:808 E:818 ||| JJ
in  ||| S:818 E:821 ||| IN
patients  ||| S:821 E:830 ||| NNS
with  ||| S:830 E:835 ||| IN
negative  ||| S:835 E:844 ||| JJ
craniocerebral  ||| S:844 E:859 ||| JJ
tomography  ||| S:859 E:870 ||| JJ
results ||| S:870 E:877 ||| NNS
,  ||| S:877 E:879 ||| ,
confirming  ||| S:879 E:890 ||| VBG
the  ||| S:890 E:894 ||| DT
diagnostic  ||| S:894 E:905 ||| JJ
value  ||| S:905 E:911 ||| NN
of  ||| S:911 E:914 ||| IN
this  ||| S:914 E:919 ||| DT
biomarker ||| S:919 E:928 ||| NN
.  ||| S:928 E:930 ||| .
A  ||| S:930 E:932 ||| DT
prognostic  ||| S:932 E:943 ||| JJ
value  ||| S:943 E:949 ||| NN
of  ||| S:949 E:952 ||| IN
the  ||| S:952 E:956 ||| DT
biomarker  ||| S:956 E:966 ||| NN
in  ||| S:966 E:969 ||| IN
the  ||| S:969 E:973 ||| DT
context  ||| S:973 E:981 ||| NN
of  ||| S:981 E:984 ||| IN
minor  ||| S:984 E:990 ||| JJ
head  ||| S:990 E:995 ||| NN
injury  ||| S:995 E:1002 ||| NN
is  ||| S:1002 E:1005 ||| VBZ
also  ||| S:1005 E:1010 ||| RB
reported ||| S:1010 E:1018 ||| VBD
.  ||| S:1018 E:1020 ||| .
